Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis

Exclusion Criteria

• •Chronic use of non-protocol approved non-steroidal anti-inflammatory drugs (NSAIDs)
• •Pregnant or breast feeding female subjects.
• •Clinically significant medical condition that, in the opinion of the investigator, would place the subject at an increased risk to participate in the study.
• •An alanine aminotransferase (ALT) and aspartate aminotransferase (AST) value \>3 × upper limit of normal (ULN) that, in the medical judgment of the investigator, was due to reduced liver function or active liver disease.
• •Sexually active males with partners of childbearing potential not using highly effective contraception or not agreeing to continue highly effective contraception for at least 3 months after last dose of study drug.